Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dhanuka Agritech Ltd. Capital/Financing Update 2024

Nov 25, 2024

61335_rns_2024-11-25_1340e706-0869-4715-a1f9-eff2c7d92376.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

25[th] November, 2024

Corporate Relationship Department BSE Ltd.

Listing Department Corporate Relationship Department National Stock Exchange of India Limited BSE Ltd. Exchange Plaza, 1[st] Floor New Trading, Rotunda Building, Plot No. C/1, G. Block, P J Towers, Dalal Street Fort, Bandra- Kurla Complex, Mumbai- 400 001 Bandra East, Mumbai-400 051

Ref: Symbol- DHANUKA

Scrip Code: 507717

Sub: Intimation of the signing of Agreement by Dhanuka Agritech Limited (“Dhanuka”) with Bayer AG, Germany for the acquisition of active ingredients named “Iprovalicarb” and “ ” Triadimenol .

Ref: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

To all stakeholders

Dhanuka Agritech Ltd. has signed an Agreement with Bayer AG, Germany for the acquisition of the crop protection active ingredients named “Iprovalicarb” and “Triadimenol” along with the trademark Melody for Iprovalicarb. This Agreement signed by Dhanuka is subject to completion of certain closing actions. This acquisition will help Dhanuka to expand its business in India and in overseas markets and with this Dhanuka will make its global presence.

The above intimation is in pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time.

Further, the detailed disclosure pursuant to the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("LODR Regulations") read with Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023, is enclosed as Annexure-A.

The aforementioned information shall also be available on Dhanuka's website www.dhanuka.com

For Dhanuka Agritech Limited

Digitally signed JITIN by JITIN SADANA SADANA Date: 2024.11.25 09:18:02 +05'30' Jitin Sadana Company Secretary and Compliance Officer FCS-7612

Encl: a/a

Registered & Corporate Office : Global Gateway Towers, Near Guru Dronacharya Metro Station, MG Road, Gurugram-122002, Haryana

Tel: +91-124-434-5000, Email: [email protected], Website: www.dhanuka.com CIN: L24219HR1985PLC122802

==> picture [612 x 131] intentionally omitted <==

Annexure A

S. No Particulars Disclosures
1. Name of the Party with whom the agreement is entered Bayer AG, incorporated in
Germany
2. Purpose of entering into the agreement For the acquisition of the
active ingredients named
“Iprovalicarb” and
“Triadimenol” from an
overseas entity named
Bayer AG
3. Shareholding, if any, in the entity with whom the
agreement is executed
NIL
4. Significant terms of the agreement (in brief), special
rights like right to appoint directors, first right to share
subscription in case of issue of shares, right to restrict
any change in capital structure etc.
Dhanuka will get the rights
to sell these products in
India and various countries
outside India.
5. Whether, the said parties are related to the promoter/
promoter group/ group companies in any manner. If
yes, nature of relationship
NO
6. Whether the transaction would fall within related party
transaction? If yes, whether the same is done at “arms’
length”
NO
7. In case of issuance of shares to the parties, details of
issue price, class of shares issued
NIL
8. Any other disclosures related to such agreements, viz.
details of the nominee on the board of directors of the
listed entity, potential conflict of interest arising out of
such agreements, etc.
NIL
9. In case of termination or amendment of agreement,
listed entity shall disclose additional details to the stock
exchange(s): i. Name of the parties to the agreement ii.
Nature of the agreement iii. Date of execution of the
agreement iv. Details of the amendment and impact
thereof or reasons of termination and impact thereof
NA

Registered & Corporate Office : Global Gateway Towers, Near Guru Dronacharya Metro Station, MG Road, Gurugram-122002, Haryana Tel: +91-124-434-5000, Email: [email protected], Website: www.dhanuka.com CIN: L24219HR1985PLC122802